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Background: There is limited knowledge of Klebsiella pneumoniae determinants implicated in the blocking of the NF-B
signaling pathway.
Results:Ahigh-throughput genetic screen led to the identification of 114 putativeK. pneumoniae genes that are associatedwith
suppression of NF-B activation.
Conclusion: CPS, LPS, and the T2SS-secreted PulA are needed for immune evasion.
Significance: A new therapeutic approach to treat Klebsiella infections will be the prevention of immune evasion.
Klebsiella pneumoniae is an etiologic agent of community-
acquired and nosocomial pneumonia. It has been shown that
K. pneumoniae infections are characterized by reduced early
inflammatory response. Recently our group has shown that
K. pneumoniae dampens the activation of inflammatory
responses by antagonizing the activationof theNF-Bcanonical
pathway. Our results revealed thatK. pneumoniae capsule poly-
saccharide (CPS) was necessary but not sufficient to attenuate
inflammation. To identify additionalKlebsiella factors required
to dampen inflammation, we standardized and applied a high-
throughput gain-of-function screen to examine a Klebsiella
transposonmutant library.We identified 114mutants that trig-
gered the activation of NF-B. Two gene ontology categories
accounted for half of the loci identified in the screening: metab-
olism and transport genes (32% of the mutants) and envelope-
related genes (17%). Characterization of the mutants revealed
that the lack of the enterobactin siderophore was linked to a
reduced CPS expression, which in turn underlined the NF-B
activation induced by themutant. The lipopolysaccharide (LPS)
O-polysaccharide and the pullulanase (PulA) type 2 secretion
system (T2SS) are required for full effectiveness of the immune
evasion. Importantly, these factors do not play a redundant role.
The fact that LPS O-polysaccharide and T2SS mutant-induced
responses were dependent on TLR2-TLR4-MyD88 activation
suggested that LPS O-polysaccharide and PulA perturbed Toll-
like receptor (TLR)-dependent recognition of K. pneumoniae.
Finally, we demonstrate that LPS O-polysaccharide and pulA
mutants are attenuated in the pneumonia mouse model. We
propose that LPS O-polysaccharide and PulA T2SS could be
new targets for the design of new antimicrobials. Increasing
TLR-governed defense responses might provide also selective
alternatives for the management of K. pneumoniae pneumonia.
Klebsiella pneumoniae is a Gram-negative pathogen causing
awide range of infections fromurinary tract infections to pneu-
monia.Klebsiella-triggered pneumonia is particularly devastat-
ing among immunocompromised patients with mortality rates
between 25 and 60% (1). K. pneumoniae is a member of the so-
called ESKAPE group of microorganisms to emphasize that they
effectively “escape” the effects of antibacterial drugs (2). Despite
the clinical relevance of K. pneumoniae, the infection biology of
this pathogen is poorly understood, and therefore it is both urgent
and necessary to better understand its pathophysiology to be able
to design new strategies to treatK. pneumoniae infections.
The best characterized virulence factor of this pathogen is
the capsule polysaccharide (CPS).3 IsogenicCPSmutant strains
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are avirulent and unable to cause pneumonia and urinary tract
infections (3–5). Lipid A of lipopolysaccharide (LPS), the outer
membrane proteins OmpA andOmpK36, iron-scavenging sys-
tems, and several adhesins are other virulence determinants
that have been characterized (6–10). Nonetheless, there is still
limited knowledge of the exact role of individual virulence fac-
tors in Klebsiella infections.
A wealth of evidence indicates that the activation of early
inflammatory responses is essential to clear Klebsiella infec-
tions (11–14). Any interference with this response leads to a
more severe infection (15), thus in turn, augmenting the
immune response with exogenous inflammatory mediators
decreases the mortality associated with K. pneumoniae infec-
tion (16–19). Collectively, this evidence suggests thatKlebsiella
tries to counteract the induction of these host defense
responses. Indeed, we (8, 20–22) and others (23) have provided
compelling evidence for this notion.
At the molecular level, we have demonstrated that K. pneu-
moniae abrogates the activation of inflammatory responses by
targeting NF-B and MAPK signaling pathways (22, 24). Kleb-
siella antagonizes the activation of NF-B via the deubiquiti-
nase CYLD and blocks the phosphorylation of MAPKs via the
MAPK phosphatase MKP-1 (22). CYLD and MKP-1 are nor-
mally regulated to return to homeostasis after inflammation to
protect the host from an overwhelming inflammatory response
(25, 26). To exert this anti-inflammatory effect, K. pneumoniae
affects the membrane association of the receptor NOD1 (22).
This is dependent on Klebsiella-triggered Rho GTPase Rac1
inhibition (22). To identify additional host factors involved in
the anti-inflammatory effect, we applied an unbiased high-
throughput siRNA gain-of-function screen to interrogate the
human kinome (24). Follow-up validation revealed that
K. pneumoniae exploits an EGF receptor (EGFR)-PI3K-AKT-
PAK4-ERK-GSK3 signaling pathway to induce the expression
of the deubiquitinase CYLD to attenuate the cytokine-depen-
dent nuclear translocation ofNF-B (24).Our group uncovered
a role for CPS in the activation of EGFR and EGFR-dependent
signaling (24). However, because CPS does not activate NOD1-
dependent responses (22), K. pneumoniae may employ addi-
tional factors to attenuate NF-B activation.
This study was designed to identify K. pneumoniae determi-
nants implicated in blocking the activation of theNF-B signal-
ing pathway. To take a systematic approach toward the identifi-
cation of these bacterial factors, we performed a high-throughput
genetic screen tominea transposonmutant library ofK. pneumo-
nia strain 52145. This is a reference strain of serotype K2 highly
virulent Klebsiella strains from which important virulence fac-
tors, including the large virulence plasmid harboring the regu-
lator of mucoid phenotype (rmpA) and the aerobactin cluster,
have been identified (27). We found 114 mutants that, in
sharp contrast to the wild-type strain, activated the NF-B
signaling pathway. Further characterization confirmed the
critical role of K. pneumoniae CPS in blocking NF-B acti-
vation and uncovered the role of the LPS polysaccharide
section and the pullulanase type II secretion system (T2SS)
in immune evasion.
Experimental Procedures
Bacterial Strains, Growth Conditions, and Reagents
Strains and plasmids used in this study are listed in Table 1.
K. pneumoniae 52145 (hereafter Kp52145) is a clinical isolate
(serotype O1:K2) described previously (3, 28). Bacteria were
grown in Luria-Bertani (LB) medium at 37 °C unless indicated
otherwise. When appropriate, antibiotics were added to the
growth medium at the following concentrations: ampicillin,
100g/ml; rifampicin, 50g/ml; kanamycin, 50g/m; cloram-
phenicol (Cm), 25 g/ml; and trimethoprim (Tp), 100 g/ml.
FeSO4, and FeCl3 were used at a concentration of 10 M, and
2-2-dipyridyl (Sigma) was used at a concentration of 200 M.
The sequences of the primers used in this study are available
from the authors upon request.
Cell Culture and Infection
Monolayers of A549 (ATCC CCL185) were grown as
described previously (22). For infections, A549 cells were
seeded to 90% confluence (3 105 cells/well) in 24-well tissue
culture plates. Cells were serum-starved for 16 h before infec-
tion. Bacteria were prepared as described (22), and infections
were performed using a multiplicity of infection of 100 bacteri-
a/cell unless indicated otherwise. For incubation times longer
than 120min, bacteria were killed by the addition of gentamicin
(100g/ml), which was not removed until the end of the exper-
iment. Cell viability, assessed by trypan blue dye exclusion, was
95% even after 4 h of infection.
Mutant Library Construction
Kp52145 was made electrocompetent following the method
described by Sharma and Schimke (29). Transposonmutagenesis
was performed by electroporating1 g of the pRL27 mini Tn5
transposon (30) to 50l of Kp52145 electrocompetent cells using
a Gene Pulser Xcell (Bio-Rad) followed by a 60-min recovery in
SOC (super optimal broth)medium at 37 °C. The transposon car-
ries a kanamycin resistance cassette and an R6K origin of replica-
tion (30). Transposants were plated on LB-rifampicin-kanamycin
plates, and the transposon mutant library was generated from six
independentelectroporationrounds.A totalof5320mutantswere
arrayed in a 96-well plate format and stored at80 °C in 20% (v/v)
glycerol (master plate). One well without bacteria was kept as a
negative control in all plates (typically well H12). Random trans-
poson insertion was checked in 200 clones by direct genomic
sequencing.GenomicDNAwas extracted using theRealpure spin
kit (Real). Sequencing reaction was performed in an iCycler (Bio-
Rad) containing 2l of BigDyeMasterMix, 2l of 5 buffer, 1l
of betaine (5 M), 1 M primer (tpnRL17), and 2–5 g of genomic
DNA.The thermal profile consisted of 5min of a denaturalization
step at 95 °C followed by 100 cycles of 95 °C for 30 s, 50 °C for 20 s,
and 60 °C for 4min. Sequencing reactions were purified following
the manufacturer’s instructions, resuspended in 10 l of Hi-Di
formamide, and run in an ABI 3730 genome sequencer (Applied
Biosystems).
Construction of a NF-B Reporter Cell Line
A549cellswere seeded into24-well plates at adensityof 4104
cells/well and transfected 24 h later with 5 g of pNifty2-SEAP
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(InvivoGen) usingLipofectamine 2000 (Invitrogen) lipofection re-
agentaccording to themanufacturer’s instructions. In thepNifty2-
SEAPvector, the proximal promoter of the endothelial cell-leuko-
cyte adhesion molecule (ELAM-1; E-selectin), containing three
NF-B sites and lacking anAP1/CREB (cAMP-response element-
binding protein) site found in the full-length promoter, controls
the reporter gene, SEAP (secreted form of the human embryonic
alkaline phosphatase). Twenty-four hours after transfection, cells
were selected with 500 g/ml Zeocin for 2 weeks (InvivoGen).
Cells were singularized by serial dilutions in 96-well plates, and
monoclonal cell lines were propagated for 2 weeks. Stably trans-
fected A549-SEAP cells were grown in complete RPMI medium
supplemented with 100 g/ml Zeocin. A2 was the clone selected
for screening purposes.
High-throughput Screening
Cell Seeding and Bacterial Culture—A549-SEAP A2 cells
from the same passage number were seeded into 96-well plates
at 1–2  104 cells/well in 100 l of RPMI 1640. Transposon
mutants and controls were grown in 96-well plates. 5 l from
the bacteria master plate were used to inoculate 150 l of LB
supplemented with the appropriate antibiotics. Plates were
incubated overnight at 37 °C without shaking. Bacterial growth
was determined by measuring absorbance at 600 nm (A600)
using a microplate reader (Biotek PowerWave HT).
Infection—A549-SEAP A2 cells were washed twice with 200
l of PBS, and then 150 l of RPMI 1640 supplemented with
10% fetal calf serum (FCS) was added. Five l of the bacterial
overnight culture was used to infect the cells (multiplicity of
infection,100:1). Only the inner 60wells of the platewere used.
Tworeplicatesof eachcontrol (negative/positive (IL-1, 10ng/ml)
cells infected with Kp52145, 52OmpA, 52145wcaK2, and
52145wcaK2-OmpA) and 48 mutants were run in each plate.
After 3 h, wells were washed twice with 200l of PBS, and then
100 l of RPMI 1640 containing 100 g/ml of gentamicin was
TABLE 1
Bacterial strains and plasmids used in this study
Bacterial strains and plasmids Genotype or comments Source or reference
Strains
Escherichia coli
CC118-pir (ara-leu)7967 araD139 lacX74 galE galK phoA20 thi-1 rpsE rpoB argE(Am) recA1 Laboratory collection
DH5a-pir DlacU169 (F80lacZDM15) recA1 endA1 hsdR17 thi-1 gyrA96 relA1 pir phage lysogen Laboratory collection
SY327-pir (lac pro) argE (Am) rif nalA recA56 (pir) Laboratory collection
Klebsiella pneumoniae
Kp52145 Clinical isolate; serotype O1:K2; RifR (3, 28)
52145-wcaK2 Kp52145, wcaK2, capsule mutant; RifR (32)
52OmpA2 Kp52145, ompA::Cm, ompA gene is inactivated; RifR, CmR (37)
52wcaK2OmpA 52145-wcaK2, ompA::Cm, capsule mutant in which ompA is inactivated; RifR, CmR (37)
52waaL Kp52145, waaL, waaL is inactivated; nonpolar mutant; RifR (68)
52wabM Kp52145, wabM, wabM is inactivated; nonpolar mutant; RifR (50)
52wabH Kp52145, wabH, wabH is inactivated; nonpolar mutant; RifR (50)
52wabK Kp52145, wabK, wabK is inactivated; non polar mutant; RifR (50)
52145-wcaK2waaL 52145-wcaK2; waaL, waaL is inactivated; non polar mutant; RifR (6)
52145-wcaK2wabM 52145-wcaK2; wabM, wabM is inactivated; non polar mutant; RifR (6)
52145-wcaK2wabK 52145-wcaK2; wabK, wabK is inactivated; non polar mutant; RifR (6)
52145-wcaK2wabH 52145-wcaK2; wabH, wabH is inactivated; non polar mutant; RifR (6)
52waaL::tn5 Kp52145; waaL::tn5, waaL is inactivated; RifR, KmR This study
52entF::tn5 Kp52145; entF::tn5, entF is inactivated; RifR, KmR This study
52145-wcaK2entF 52145-wcaK2, entF:: pKNOCK-Cm_entF, capsule mutant in which entF is inactivated;
RifR, CmR
This study
52pulC::tn5 Kp52145; pulC::tn5, pulC is inactivated; RifR, KmR This study
52irp1 Kp52145, irp1:: pKNOCK-Cm_IRP1, irp1 is inactivated; RifR, CmR This study
52iutA Kp52145, iutA:: pKNOCK-Cm_iutA, iutA is inactivated; RifR, CmR This study
52glf Kp52145, glf:: pSFglf, glf is inactivated; RifR, KmR This study
52pulA Kp52145, pulA:: pKNOCK-Cm_pulA, pulA is inactivated; RifR, CmR This study
52pulACom 52pulA harboring mini-Tn7TKmKpnpulA; PulA levels restored; RifR, CmR, KmR This study
52145-wcaK2pulA 52145-wcaK2, pulA:: pKNOCK-Cm_pulA, capsule mutant in which pulA is inactivated;
RifR, CmR
This study
52145-wcaK2pulACom 52145-wcaK2pulA mutant harboring mini-Tn7TKmKpnpulA; PulA levels restored;
RifR, CmR, KmR
This study
52waaLpulA 52waaL, pulA:: pKNOCK-Cm_pulA, waaLmutant in which pulA is inactivated;
RifR, CmR
This study
52145-wcaK2waaL pulA 52145-wcaK2waaL, pulA:: pKNOCK-Cm_pulA, capsule and waaLmutant in which pulA
is inactivated; RifR, CmR
This study
Plasmids
pRL27 Tn5 transposon delivery vector, KmR (30)
pGEM-T Easy Cloning plasmid, AmpR Promega
pKNOCK-Cm Suicide vector, R6K replication origin, CmR (35)
pKNOCK-Cm_entF pKNOCK-Cm containing an internal fragment of entF gene for mutant construction, CmR This study
pKNOCK-Cm_IRP1 pKNOCK-Cm containing an internal fragment of irp1 gene for mutant construction, CmR This study
pKNOCK-Cm_iutA pKNOCK-Cm containing an internal fragment of iutA gene for mutant construction, CmR This study
pKNOCK-Cm_pulA pKNOCK-Cm containing an internal fragment of pulA gene for mutant construction, CmR This study
pSF100 Suicide vector, R6K replication origin, KmR (36)
pSFglf pSF100 containing an internal fragment of glf gene for mutant construction, KmR This study
pUC18R6KT-mini-Tn7TKm pUC18R6KT-mini-Tn7TKm containing a Km cassette, AmpR, KmR (37)
pTSNSK-Tp pTSNSK-Tp containing a transposase for Tn7 insertion, KmR, TpR (38)
pUC18R6KT-mini-Tn7TKm_pulACom pUC18R6KT-mini-Tn7TKm containing pulA gene for complementation, AmpR, KmR This study
p34S-Tp Source of Tp cassette; AmpR, TpR (40)
pPROBE-gfp[LVA] Plasmid containing gfp without promoter as reporter gene, KmR (41)
pPROBE-gfp[LVA]Tp Trimethoprim resistance cassette cloned into SphI site of pPROBE-gfp[LVA], TpR This study
pPROBE-gfp[LVA]Tp_entC pPROBE-gfp[LVA]Tp containing entC promoter region, TpR This study
pPROBE-gfp[LVA]Tp_ybtA pPROBE-gfp[LVA]Tp containing ybtA promoter region, TpR This study
pPROBE-gfp[LVA]Tp_psn pPROBE-gfp[LVA]Tp containing psn promoter region, TpR This study
pPROBE-gfp[LVA]Tp_iucA pPROBE-gfp[LVA]Tp containing iucA promoter region, TpR This study
pGPLKpnCps pGPL01 containing cps promoter region; AmpR (37)
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added to eachwell. Plateswere incubated overnight in a humid-
ified CO2 incubator.
Colorimetric Assay—30l of the supernatant wasmixedwith
200 l of QUANTI-Blue reagent (InvivoGen), and the mixture
was incubated at 37 °C for 24 h. The levels of SEAP were mea-
sured at an absorbance at 625 nm (A625).
Statistical Analysis—The Z score was calculated for each of
the 48 wells of a plate as described previously (31). For a given
well, the Z score was calculated by subtracting the mean value
of the wells on that plate from the value of the well and dividing
by the standard deviation value for all the plate wells. A Z
score  2 was considered significant. As means and standard
deviations are greatly influenced by statistical outliers (31),
which in the context of a screening are putative hits, we also
selected mutants that induced SEAP levels higher than A625
0.5, which represents a 2-fold A625 value induced by the wild-
type strain.
Hit Validation—Four independent validation rounds were
run for each selected hit. A hit was considered validated if the
SEAP levels were A625  0.5 in at least two of four validation
runs.
Transposon Insertion Site Identification—GenomicDNAwas
purified using the Realpure spin kit (Real). Direct genomic
sequencing was carried out as described above (see “Mutant
Library Construction”).
Growth Deficiency Determination—To identify those hits
with growth deficiencies, transposon mutants were plated on
LB plates or M9 plates supplemented with either 0.2% glucose
or 10 mM citrate and incubated at 37 °C for 48 h.
CPS Purification andQuantification
Cell-associated CPS from K. pneumoniae strains were puri-
fied using the hot phenol-water method exactly as described
previously (32). CPSwas quantified by determining the concen-
tration of uronic acid in the samples using amodified carbazole
assay (33).
LPS Extraction and Analysis by SDS-PAGE
The LPS from K. pneumoniae strains was extracted by a
modified phenol-water purification method (34). The LPS was
run on a 12% SDS-PAGE and visualized using a Pro-Q Emerald
300 lipopolysaccharide gel stain Kit (Invitrogen).
K. pneumoniaeMutant Construction
The entF, irp1, iutA, and pulAmutants were constructed by
insertion mutagenesis using the pKNOCK-Cm suicide vector
(35). An internal fragment of each gene was amplified using
genomic DNA from wild-type K. pneumoniae 52145, Vent po-
lymerase (NewEnglandBiolabs), and the corresponding primer
pairs. PCR products were phosphorylated and cloned into the
SmaI-digested and dephosphorylated pKNOCK-Cm vector to
obtain pKNOCK-Cm_entF, pKNOCK-Cm_irp1, pKNOCK-
Cm_iutA, and pKNOCK-Cm_pulA, respectively. The glf
mutant was also constructed by insertion mutagenesis using
the pir replication-dependent plasmid pSF100 (36). Plasmids
were introduced into Klebsiella by conjugation and PCR, or
Southern blot was used to identify strains in which plasmids
were inserted into the genome by homologous recombination.
Complementation of pulAMutant
To complement the pulAmutant, a DNA fragment of 4,008
bp containing the putative promoter region and coding region
of pulA was PCR-amplified (primer pair pulACom.F-pul
ACom.R) using Vent polymerase, gel-purified, and cloned into
SmaI-digested pUC18R6KT-mini-Tn7TKm (37) to obtain
pUC18R6KT-mini-Tn7TKm_pulACom. The pTSNSK-Tp
plasmid, which contains the transposase tnsABCD, necessary
for Tn7 transposonmobilization (38), was electroporated into the
pulAmutant. Then, the pUC18R6KT-mini-Tn7TKm_pulACom
plasmidwasmobilized into this strain by triparental conjugation
using the helper strain Escherichia coliHB101/pRK2013. Colo-
nies were screened for resistance to kanamycin and sensitivity
to ampicillin. Because the ampicillin cassette is located outside
of theTn7 region on the vector, sensitivity to ampicillin denotes
the integration of the Tn7 derivative at the attTn7 site instead
of incorporation of the vector into the chromosome. Confirma-
tionof integrationof theTn7 transposon at the establishedattTn7
site located downstream of the glmS gene was verified by a multi-
plex PCR using primers glmS.UP, glmS.DW, Tn7.L, and Tn7.R.
PCR reactions were performed in a final volume of 25 l con-
taining 50 ng of DNA, 1.5 mM MgCl2, 0.2 mM dNTPs, each
primer at 0.2 M, and 1 unit of GoTaq polymerase (Promega).
The thermal profile was as follows: an initial denaturation step
at 94 °C for 5min followed by 5 cycles of 94 °C for 45 s, a touch-
down from 62 to 58 °C for 45 s and 72 °C for 45 s, and then 25
cycles of 94 °C for 45 s, 58 °C for 45 s, and 72 °C for 45 s, and a
final extension step at 72 °C for 5 min. Correct insertion of the
Tn7 transposon yielded two amplicons of 462 and 216 bp ampli-
fied with primer pairs glmS.UP-Tn7.L and glmS.Dw-Tn7.R,
respectively. Only one amplicon of 455 bp, corresponding to an
internal fragment of the glmS gene, was amplified when used as
the template DNA from wild-type Klebsiella. pTSNSK-Tp
from the recipient strain was cured by growing bacteria at 37 °C
due to the plasmid-thermosensitive origin of replication
pSC101. Plasmid removal was confirmed by susceptibility to
trimethoprim.
PulA levels on the outer membrane fraction, purified as
described previously (39), were detected by immunoblotting
using rabbit antibody anti-PulA (1:1000), kindly donated by A.
Pugsley. Proteinswere resolved using 12% SDS-PAGE and elec-
troblotted to nitrocellulose membrane. Membranes were
blockedwith 4% skimmilk in TBST (137mMNaCl, 2.7mMKCl,
19 mM Tris base (pH 7.4)).
ConstructionofgfpReporter Fusions
A trimethoprim resistance cassette was obtained as a SmaI
fragment from plasmid p34S-Tp (40). The cassette was
cloned into SphI-digested and blunt-ended plasmid pPROBE-
gfp[LVA] to obtain pPROBE-gfp[LVA]Tp. This vector con-
tains a promoterless gfp gene (41). DNA fragments containing
the promoter regions of entC, ybtA, psn, and iucA were ampli-
fied by PCR using Vent polymerase, gel-purified, and cloned
into SmaI-digested pPROBE-gfp[LVA]Tp plasmid. Plasmids
were introduced in E. coli DH5-pir and then mobilized into
Klebsiella by triparental conjugation using the helper strain
E. coli HB101/pRK2013.
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Luciferase Activity and GFP FluorescenceMeasurements
Overnight cultures of the reporter strains were diluted 1/10
in fresh LBmedium and incubated for 3 h at 37 °C on an orbital
incubator shaker (180 rpm). The cultures were harvested
(4000 g for 20 min) and resuspended to anA600 of 1.0 in PBS.
Luciferase activity and GFP fluorescence were determined as
described previously and expressed as relative light units (RLU)
or relative fluorescence units (RFU) (42). All measurements
were performed in triplicate on at least three independent
occasions.
Adhesion and Internalization Assays
Bacteria adhesion and internalization to A549 cells were
determined as our group described previously (8). The results
are expressed as cfu/well. Experiments were carried out in
duplicate on at least three independent occasions.
IL-8 Stimulation Assay
A549 cells, seeded in 24-well plates, were infected for 2 h and
then washed twice with PBS, and fresh medium plus gentami-
cin (100 g/ml) was added. Supernatants were recovered after
12 h, cell debris was removed by centrifugation, and samples
were frozen at 80 °C. IL-8 levels in the supernatants were
determined using a commercial ELISA (eBioscience) with a
sensitivity of2 pg/ml. Experiments were run in duplicate and
repeated at least three independent times.
Inmunoblotting
Eukaryotic proteins were resolved by standard 10% SDS-
PAGE and electroblotted onto nitrocellulose membranes.
Membranes were blockedwith 4% skimmilk in TBST, and pro-
tein bands were detected with specific antibodies using chemi-
luminescence reagents and a GeneGnome chemiluminescence
imager (Syngene). Immunostainings for IB were performed
using polyclonal rabbit anti- IB (1:1,000, Cell Signaling) anti-
bodies. Immunostainings to assess phosphorylation ofp38, p44/
42, and JNKMAPKswereperformedusingpolyclonal rabbit, anti-
phospho-p38, anti-phospho-p44/42, and anti-phospho-JNK
antibodies, respectively (all used at 1:1000; Cell Signaling). Blots
were reprobed with the polyclonal antibody anti-human tubu-
lin (1:3000, Sigma) to control that equal amounts of proteins
were loaded in each lane.
Small Interfering RNA (siRNA)
Transfection of siRNAs was performed at the time of cell
seeding in a 96-well plate format (2  104 cells/well). Lipo-
fectamineTM 2000 transfection reagent (Invitrogen) was used
following the manufacturer’s instructions. Transfection exper-
iments were carried out in Opti-MEM reduced serummedium
(Invitrogen). siRNAswere used at a concentration of 20 nM, and
experiments were carried out 48 h after transfection. The
knockdown efficiency of the siRNAs targeting NOD1, TLR2,
TLR4, and EGFR was verified previously (22, 24).
Murine InfectionModel
Mice were treated in accordance with the Directive of the
European Parliament and theCouncil on the Protection of Ani-
mals Used for Scientific Purposes (Directive 2010/63/EU) and
in agreement with the Bioethical Committee of the University
of the Balearic Islands. This study was approved by the Bioethi-
cal Committee of theUniversity of the Balearic Islands (author-
ization number 1748).
Five-to-seven-week-old female CD-1 mice (Harlan) were
infected as described previously by our group (8). Non-infected
mice were inoculated with 20 l of PBS. At 24 h post-infection,
mice were euthanized by cervical dislocation. Tissues were rap-
idly dissected for bacterial load determination, and half of the
lungs were immediately frozen in liquid nitrogen and stored at
80 °C until purification of RNA was carried out.
RNA Purification and Real TimeQuantitative PCR (RT-qPCR)
RNA from lungs was purified as described by us (8). cDNA
was obtained by retrotranscription of 1 g of total RNA using
the M-MLV reverse transcriptase (Sigma). The reaction
included one step to eliminate traces of genomic DNA. RT-
qPCR analyses were performed using an iCycler real-time PCR
instrument (Bio-Rad). Reactions were performed in 25 l con-
taining 12.5 l of KAPA SYBR FAST qPCR kit master mix
(KapaBiosystems), each primer at 0.2 M, and 50 ng of cDNA.
Relative quantities of mRNAswere obtained using the compar-
ative threshold cycle (CT) method by normalizing to hprt1.
Bacteria were grown at 37 °C in 5 ml of LB medium on an
orbital incubator shaker (180 rpm) until an A600 of 0.3 was
reached. RNA was purified following an established protocol
(43). cDNA was obtained by retrotranscription of 2 g of total
RNA using commercial M-MLV reverse transcriptase (Sigma)
and random primers mixture (SABiosciences, a Qiagen com-
pany). 50 ng of cDNAwas used as a template in a 25-l reaction.
RT-PCR analyses were performed with a Smart Cycler real-
time PCR instrument (Cepheid, Sunnyvale, CA) using a
KapaSYBRFast qPCRkit as recommendedby themanufacturer
(Cultek). SYBR Green dye fluorescence was measured at 521
nm. cDNAs were obtained from two independent extractions
of mRNA, and each one was amplified by RT-qPCR on two
independent occasions. Relative quantities of wabM mRNAs
were obtained using the comparative threshold cycle (CT)
method by normalizing to the rpoD gene.
Statistical Analysis
Results were analyzed by analysis of variance (ANOVA) or
with a one-tailed t test followed by a Bonferroni contrast cor-
rection for multiple testing using GraphPad Prism software
(GraphPad Software Inc.). Results are given as themeans	 S.D.
A p value of0.05 was considered statistically significant.
Results
High-throughput Screening to Identify K. pneumoniae Loci
Involved in Attenuating NF-B Activation—We developed an
assay suitable for identifying theK. pneumoniae loci required to
block activation of theNF-Bpathway.Anew indicator cell line
was engineered by transfection of the human epithelial cell line
A549 with the reporter vector pNIFTy2-SEAP (InvivoGen).
Three clones were selected, A549-SEAP A2, D2, and D4, and
control experiments were carried out to determine whether
different stimuli known to activate NF-B induce the secretion
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of SEAP (Fig. 1A). Clone A2 secreted higher amounts of SEAP
than the other two clones after cells were challenged with dif-
ferent stimuli (Fig. 1A). Time course experiments showed that
clone A2 secreted higher levels of SEAP over time than the
other two clones upon challenge with IL-1 (10 ng/ml) (Fig.
1B).Western blot analysis of IB levels showed no differences
between A549 cells and A549-SEAP A2 after stimulation with
different agonists (Fig. 1C). CloneA2was selected for screening
purposes.
SEAP levels induced by Kp52145 were not significantly dif-
ferent than those observed in non-infected cells (Fig. 2A). In
contrast, the cps, ompA mutants, and the cps-ompA double
mutant did trigger the secretion of SEAP. We have already
reported that these strains elicit the activation of NF-B (8).
The differences observed between strains are consistent with
data from our laboratory showing the relative importance of
CPS and OmpA to attenuate NF-B activation (8).
The assay was then transferred from a 24-well format to a
96-well format by optimizing culture conditions, cell number/
well, multiplicity of infection, time of contact, and time of
detection of secreted SEAP. To determine the quality of the
assay, the Z factor (31) was calculated taking as a negative
control SEAP levels secreted by cells infectedwith thewild-type
strain and as a positive control SEAP levels secreted by cells
infected with the ompAmutant or cells stimulated with IL-1.
FIGURE1.Constructionof aNF-B reporter cell line.A, SEAP levels released
by three clones of A549 cells stably transfected with NF-B reporter pNifty
2-SEAP vector. Cells were left untreated (control (CON), white bars), treated
with IL-1 (10 ng/ml), TNF (10 ng/ml), or TLR2 agonist Pam3Cys (100 ng/ml),
or infected with Klebsiella capsule mutant (52145-wzaK2) or nontypable
Haemophilus influenzae398 (NTHi). Scale bars representmean	S.E. (n
3).B,
time course of SEAP levels released by the selected clones treated with IL-1
(10 ng/ml) (n
3).C, immunoblot analysis of IB and tubulin levels in lysates
of A549 and clone A549-SEAP A2 cells were left untreated (control), treated
with IL-1 (10 ng/ml) or TNF (50 ng/ml) for the indicated time, or infected for
3hwithKp52145.Data are representative of three independent experiments.
FIGURE 2. High-throughput screening for the identification of K. pneu-
moniae factors implicated in attenuation of NF-B activation. A, SEAP
levels released by A549-SEAP A2 cells left untreated (control (CON), white
bars), treated with IL-1 (10 ng/ml) (black bars), or infected with Kp52145,
52OmpA2, 52145-wzaK2, or 52145-wcaK2ompA (gray bars). Scale bars rep-
resent mean	 S.E. (n
 3) *, p 0.05 (results are significantly different from
the results for Kp52145; one-tailed t test). B, distribution of SEAP levels
released by A549-SEAP A2 cells infectedwith themutants. C, distribution of Z
score data of SEAP levels.
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In our case, the resulting Z factors were 0.73 and 0.86 for the
respective comparisons. The Z factor is a screening window
coefficient indicating the capability of a hit identification for a
given assay at the defined screening conditions. Z factors
higher than 0.5 indicate that an assay is robust enough for a
high-throughput screening (31).
To identify Klebsiella loci involved in attenuating NF-B
activation, we examined a bank of 5320 transposon mutants.
Each mutant was tested individually. For candidate selection
the standard Z score normalization procedure was applied and
mutants with a Z score  2 were selected. We also selected
those mutants that induce SEAP levels higher than A625 0.5,
which represents a 2-fold increase in the SEAP levels induced
by the wild type. The distribution of A625 values and the Z
scores of the mutant library are shown in Fig. 2, B and C. Fol-
lowing the first round of screening, 522 mutants (10% of the
transposon library) were considered candidates for validation.
To validate the selected candidates, each onewas tested indi-
vidually in four independent screening rounds. Candidates
were considered validated if they induced SEAP levels higher
thanA625 0.5 in at least two of four independent experiments
upon infection of theA549-SEAPA2 cells. Using this validation
criterion, 114 Kp52145 mutants were considered validated
(Table 2). Control experiments showed that all mutants grew in
LB agar plates, LB broth, and RPMI 1640 complete medium,
whereas five and three mutants displayed growth deficiencies
when cultivated in M9 agar plates supplemented with glucose
and citrate, respectively (Table 2).
Transposon insertion sites were determined by genomic
sequencing using primer tpnRL17. The sequences obtained
were compared with the Kp52145 genome and plasmid
sequences (GenBankTM accession numbers FO834904,
FO834905, and FO834906) and to the reference sequence of
K. pneumoniae strain MGH78578 (GenBankTM accession
number CP000647.1). Ninety-nine insertions were found in the
chromosome, whereas nine and six were located in plasmid 1
and plasmid 2, respectively. TheMicrobesOnline and STRING
databaseswere interrogated to annotate the loci. Thirty of them
were related to metabolism, twenty were included in the cate-
gory outer membrane and envelope-related genes, nine in
transport, eight in regulation of transcription, seven in the
stress response category, and four in the category of DNA-re-
lated processes (Table 2). Interestingly, six of the insertions
were located in regions of the Kp52145 genome not present in
otherKlebsiella genomes (27). Nineteenmutants had the trans-
poson inserted in non-coding regions of the genome, and 17
were located within the coding region of hypothetical proteins.
In summary, our high-throughput genetic screen mining a
K. pneumoniae transposon library led to the identification of
114 mutants that triggered the activation of NF-B. In the fol-
lowing sectionswe describe the characterization of themutants
on the enterobactin siderophore, WaaL encoding the O-anti-
gen ligase and pullulanase T2SS. We selected the enterobactin
and ligase mutants because iron-scavenging systems and LPS
are two well characterized Klebsiella virulence determinants,
although their contributions to attenuating inflammation have
not been evaluated previously. On the other hand, we chose to
investigate the Klebsiella pullunase T2SS because its role in
Klebsiella virulence had not been established.
Analysis of the EnterobactinMutant—One transposon inser-
tion was identified in the enzyme EntF, a component of the
biosynthetic machinery of the enterobactin siderophore (44).
Enterobactin is one of the three siderophores expressed by
Kp52145 (27). Enterobactin is expressed in the lungs of infected
mice, and an enterobactin mutant is attenuated (9). As antici-
pated (9), the doubling times of the entF mutant slowed when
grown in LB supplemented with the iron chelator 2-2-dipyri-
dyl (Fig. 3A). Similar rates of growth were observed when the
wild type and themutant were grown in LB or RPMI 1640 (data
not shown).
We sought to determine whether the other two siderophores
encoded by Kp52145, aerobactin and yersiniabactin, are impli-
cated in attenuation of inflammation.However, the SEAP levels
induced by the aerobactin mutant, strain 52iutA, and the yers-
iniabactin mutant, strain 52irp1, were not significantly differ-
ent than those induced by the wild-type strain (Fig. 3B). In con-
trast, SEAP levels induced by the entFmutant were higher than
those induced byKp52145, which in turn, were not significantly
different than those found in the supernatant of non-infected
cells (Fig. 3B). In the canonical NF-B activation pathway,
nuclear translocation of NF-B is preceded by phosphorylation
and subsequent degradation of IB (45). Immunoblot analysis
demonstrated that the entFmutant induced the degradation of
IB in A549 cells (Fig. 3C).
These findings suggested that enterobactin, but not the other
siderophores, was expressed under our infection conditions. To
monitor the transcription of the siderophores quantitatively,
transcriptional fusions were constructed in which a promoter-
less gfp gene was under the control of the iutA, psn, ybtA, and
entC promoter regions (see “Experimental Procedures”). iutA
has been used previously to study aerobactin expression and
psn and ybtA to analyze yersiniabactin expression, whereas
entC has been used to determine enterobactin expression (9).
gfp fusions were introduced into Kp52145, and fluorescence
was determined after growing the reporter strains in LB, LB
supplemented with iron chelator 2-2-dipyridyl, or RPMI 1640
(Fig. 3D). The entC::gfp fusionwas the only one expressed under
iron-limited conditions, LB plus 2-2-dipyridyl and RPMI 1640
(Fig. 3D). It has been reported previously that bacteria up-reg-
ulate iron-scavenging systems when grown in tissue culture
medium (46). Further confirming this finding, the addition of
FeCl3 to RPMI 1640 decreased the expression of the entC::gfp
fusion by 75% (9106	 850 RFU and 2190	 323 RFU, respec-
tively; p 0.05, one-tailed t test).
Collectively, our data are consistent with a model in which
K. pneumoniae experiences a poor iron environment when
infecting A549 cells, hence leading to the activation of the sid-
erophore enterobactin. There are reports suggesting that sid-
erophoresmay inhibit immune responses (47), hencemaking it
possible that enterobactin may directly attenuate NF-B acti-
vation. However, it has been also shown that K. pneumoniae
CPS expression is down-regulated in iron-poor media (48).
Therefore, the involvement of enterobactin in attenuating
NF-B activation would be indirect considering that CPS is
known to preventNF-Bactivation (20, 21). Indirectly support-
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TABLE 2
K. pneumoniae transposonmutants validated in the screening
Function Mutant code Gene Kp52145 locus tag MGH78578 locus tag Growtha
Metabolism
Oxydoreductases P017C4 Pyrroline-5-carboxylate reductase KpST66_1303 KPN_00329 N/N
P019E9 Putative oxidoreductase KpST66_1547 KPN_00505 N/Y
P033F6 Cytochrome bd-I oxidase subunit I KpST66_2291 KPN_01153 Y/Y
P037H10 Putative alcohol dehydrogenase groES KpST66_2527 KPN_01466 Y/Y
P037H6 -Aminobutyraldehyde dehydrogenase KpST66_3019 KPN_01924 Y/Y
P035C5 Uncharacterized protein conserved KpST66_3673 KPN_02456 Y/Y
P018C10 NADH-quinone oxidoreductase subunit F KpST66_3892 KPN_02674 Y/Y
P006E12 Putative uncharacterized protein KpST66_0795 KPN_03309 Y/Y
P026H10 cueO KpST66_4209 KPN_00131 Y/Y
Carbohydrates P036D12 NADPH-dependent preQ0 reductase KpST66_3564 Unknown function Y/Y
P043B5 N-Acetylmuramic acid 6-phosphate etherase KpST66_2662 KPN_01553 Y/Y
P037E12 Deoxyribose-phosphate aldolase KpST66_2812 KPN_01702 Y/Y
P029H4 Putative Carboxymuconolactone decarboxylase family protein KpST66_1120 KPN_03003 Y/Y
P009G9 Propanediol dehydratase medium subunit pduD KpST66_0902 KPN_03206 Y/Y
P025D5 Altronate hydrolase KpST66_0586 KPN_03519 Y/Y
P006H10 L()-tartrate dehydratase subunit  (L-TTD ) KpST66_0481 KPN_03639 Y/Y
P040B5 C-terminal of putative uncharacterized protein yhjS KpST66_0231 KPN_03886 Y/Y
Lipids P025C1 Putative acetyltransferase KpST66_0118 KPN_03989 Y/Y
P026E12 Putative acetyltransferase KpST66_0118 KPN_03989 Y/Y
P035E6 acyl carrier protein KpST66_3624 A79E_1666 Y/Y
P035D1 Glycerol dehydratase, small subunit KpST66_0621 KPN_03488 Y/Y
P038H3 Putative uncharacterized protein KpST66_4890 Unknown function Y/Y
P007C12 Triacylglycerol lipase pKpST66–1_0006 Unknown function Y/Y
P038C2 C-terminal region of triacylglycerol lipase pKpST66–1_0006 Unknown function Y/Y
Amino acids P019F6 Dihydroxy-acid dehydratase KpST66_4589 KPN_04270 N/N
P037B8 Ketol-acid reductoisomerase KpST66_4586 KPN_04273 Y/N
Others P044A12 Uncharacterized protein ynjA KpST66_2352 KPN_01217 Y/Y
P040B2 Enterobactin synthase component F, entF KpST66_1661 KPN_00605 Y/Y
P005E9 Cyclic diguanylate phosphodiesterase KpST66_4039 KPN_02828 Y/Y
P037G9 Putative amidohydrolase KpST66_1569 KPN_00523 Y/Y
Envelope
Protein secretion P044G9 Putative member of ShlA/HecA/FhaA exoprotein family KpST66_1736 KPN_00676 Y/Y
P035G10 C-terminal of putative uncharacterized protein ECs0126 KpST66_4210 KPN_00130 Y/Y
P038F11 Pullulanase secretion envelope pulC KpST66_4179 KPN_00161 Y/Y
P044E5 Putative hemolysin activator protein KpST66_1737 KPN_00677 Y/Y
P020H1 Acriflavine resistance protein A, acrA KpST66_0069 KPN_04039 Y/Y
P018H5 Auxiliary transport protein, membrane fusion protein (MFP) family KpST66_3658 Unknown function Y/Y
P029G11 Putative plasmid transfer protein pKpST66–2_0082 Unknown function Y/Y
Peptidoglycan P021E7 Penicillin-binding protein 1B KpST66_4173 KPN_00164 Y/Y
P035C6 ampGmuropeptide MFS transporter KpST66_1369 KPN_00395 Y/Y
P017C10 Putative -lactamase-like KpST66_2943 KPN_01845 Y/Y
Adhesion P043A12 TPR repeat lipoprotein KpST66_0546 KPN_03571 Y/Y
P018G12 Putative fimbrial chaperone protein KpST66_4961 KPN_04471 Y/Y
P043D6 traH pKpST66–1_0057 KPN_pKPN4p07153 Y/Y
LPS P020C10 O-antigen ligase, waaL KpST66_0145 KPN_03966 Y/Y
P025F5 O-antigen ligase, waaL KpST66_0144 KPN_03966 Y/Y
Others P050B3 putative OmpA domain protein KpST66_0945 KPN_03169 Y/Y
P018C9 Putative outer membrane protein pKpST66–1_0065 AY703481 Y/Y
P018F7 Putative outer membrane protein pKpST66–1_0065 AY703481 Y/Y
P045A8 Phage tail fiber protein KpST66_2280 A79E_3050 Y/Y
P021E9 Putative fusaric acid resistance domain protein KpST66_3659 KPN2242_15265 Y/Y
Transport P025C6 Putative extracellular solute-binding protein, family 3 KpST66_1626 KPN_00572 Y/Y
P025D4 Putative extracellular solute-binding protein, family 3 KpST66_1626 KPN_00572 Y/Y
P007C1 Putative ABC transporter KpST66_2950 KPN_01850 Y/Y
P007H1 ABC-type dipeptide/oligopeptide/nickel transport systems,
permease component
KpST66_3752 KPN_02536 Y/Y
P051H4 Putative high-affinity nickel-transporter KpST66_1081 KPN_03047 Y/Y
P038C9 D-Galactonate transporter KpST66_0012 KPN_04094 Y/Y
P018G8 Spermidine/putrescine import ATP-binding protein potA KpST66_4976 KPN_04456 Y/Y
P008H2 Putative ascorbate-specific PTS system enzyme IIC KpST66_4846 KPN_04586 Y/Y
P034F5 Putative periplasmic-binding protein KpST66_1095 KPN_03033 Y/Y
Transcription P034C6 Threonyl-tRNA synthetase KpST66_3559 Unknown function Y/Y
P006G10 Transcriptional activator cadC KpST66_1540 KPN_00498 Y/Y
P019F8 HTH-type transcriptional regulator YcgE KpST66_1826 KPN_00783 Y/Y
P009C4 Putative transcriptional regulatory protein TyrR KpST66_2445 KPN_01305 Y/Y
P012G4 Putative Mgl repressor KpST66_4978 KPN_04454 Y/Y
P041F4 Putative protein YtfJ KpST66_4824 KPN_04609 Y/Y
P019G5 Putative TetR family transcriptional regulator KpST66_3249 A79E_2099 Y/Y
P038F5 Formylmethionylaminoacyl-tRNA deformylase pKpST66–2_0076 LV116 (pLVPK) Y/Y
Stress P049G10 Chaperone surA KpST66_4290 KPN_00050 N/Y
P046C4 Putative 2-component transcriptional regulator KpST66_3517 KPN_02412 Y/Y
P046H11 Protease III KpST66_0878 KPN_03230 Y/Y
P025H2 Putative uncharacterized protein yhbO KpST66_0556 KPN_03561 Y/Y
P024H5 33-kDa chaperonin KpST66_0345 KPN_03772 Y/Y
P007C4 putative -helix KpST66_0117 KPN_03990 N/Y
P044A10 DNA helicase II KpST66_4551 KPN_04312 Y/Y
DNA P012H7 Cytoskeleton protein rodZ KpST66_4055 KPN_02846 Y/Y
P029G3 Putative DNA-processing protein KpST66_0252 KPN_03865 Y/Y
P043D4 Putative integrase KpST66_0789 Unknown function Y/Y
P027A12 Putative Isrso16-transposase orfb pKpST66–2_0103 Unknown function Y/Y
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ing the latter evidence, the entFmutant expressed 50% less cell-
bound CPS than the wild-type strain (6.11	 2.99 mg/107 cells
and 11.49	 1.91mg/107 cells, respectively; p 0.05, one-tailed
t test), and the activity of the transcriptional cps::lucFF fusion
was 80% lower in the entFmutant background than in the wild-
type one (3.1 106	 16,000 RLU and 1.7 107	 34,000 RLU,
respectively; p 0.01, one-tailed t test). Further confirming the
inverse correlation between the CPS levels and the adhesion
and internalization to epithelial cells (49), the entF mutant
adhered to and was internalized by A549 cells in higher num-
bers than the wild type (Fig. 3E). Altogether, this evidence sug-
gests that entF-inducedNF-B activation could be explained by
the reduced CPS levels expressed by the mutant. To validate
this hypothesis, we asked whether the SEAP levels induced by
the entF mutant were significantly different than those trig-
gered by the cps mutant or the double cps-entF mutant. The
data shown in Fig. 3F demonstrate that indeed there were no
differences in the SEAP levels triggered by any of the three
strains.
In aggregate, our findings revealed that enterobactin was
activated under our tissue culture infection conditions and that
the lack of the siderophore was linked to a reduced CPS expres-
sion. In turn, the low CPS levels underlined the NF-B activa-
tion induced by the entFmutant.
Analysis of the LPS Polysaccharide Mutants—Two trans-
poson insertions were identified in the waaL gene. WaaL is the
O-antigen ligase responsible for ligating the LPSO-polysaccha-
ride (OPS) to the core (50). LPS analysis confirmed that neither
of the mutants express OPS, and the LPS pattern was similar to
that displayed by a nonpolar waaLmutant (50) (Fig. 4A). waaL
is encoded within the operon responsible for the synthesis of
the LPS core (50), hence making it possible that the transposon
insertion would affect the expression of downstream genes.
However, RT-qPCR experiments showed that the expression of
the downstream gene wabM was not significantly different
between the wild type and the transposon mutants (data not
shown). WabM encodes the glycosyltransferase, adding the
first glucose residue of the core where the OPS is attached (50).
The SEAP levels induced by the ligase mutants were signifi-
cantly higher than those induced by the wild type (Fig. 4B). No
significant differences were found in the SEAP levels induced
by any of the mutants (Fig. 4B).
To rule out the possibility that the non-ligated OPS exerted
an unanticipated effect on Klebsiella physiology, we tested the
glf glycosyltransferase mutant, strain 52glf. Glf is a UDP-galac-
topyranose mutase essential for OPS biosynthesis (51). Immu-
noblot analysis revealed that the ligase and OPS mutants trig-
gered the degradation of IB in A549 cells in contrast to the
TABLE 2—Continued
Function Mutant code Gene Kp52145 locus tag MGH78578 locus tag Growtha
Hypotheticals P018D10 Putative lipoprotein KpST66_3367 Unknown functionb Y/Y
P044H7 Hypothetical CDS KpST66_0778 Unknown function b Y/Y
P024E6 Putative uncharacterized protein KpST66_0788 Unknown functionb Y/Y
P034C10 Putative uncharacterized protein KpST66_4517 Unknown functionb Y/Y
P037F10 Hypothetical CDS pKpST66–1_0077 Unknown functionb Y/Y
P001G5 Subtilisin-related serine protease pKpST66–1_0111 Unknown functionb Y/Y
P054G10 Putative uncharacterized protein KpST66_0786 Unknown function Y/Y
P043E4 Hypothetical protein KpST66_3558 Unknown function Y/Y
P053H2 Putative uncharacterized protein KpST66_2293 KPN_01157 Y/Y
P013G3 Putative uncharacterized protein KpST66_2888 KPN_01793 Y/Y
P020B12 Uncharacterized protein conserved KpST66_3673 KPN_02457 Y/Y
P043G3 Cyclic diguanylate phosphodiesterase domain
protein
KpST66_0830 KPN_03274 Y/Y
P043G2 Putative uncharacterized protein KpST66_0943 KPN_03171 Y/Y
P025G5 Putative uncharacterized protein KpST66_0942 KPN_03172 Y/Y
P045H10 Hypothetical CDS pKpST66–1_0020 KPN_pKPN3p05993 Y/Y
P034F4 Hypothetical CDS pKpST66–2_0092 KP1_p117 Y/Y
P043D5 Putative uncharacterized protein pKpST66–2_0058 LV102a (pLVPK) Y/Y
Non-coding regions P007G6 Between C4-type zinc finger protein, DksA/TraR
family and GTP cyclohydrolase I
KpST66_3567 and KpST66_3568 Unknown function Y/Y
P009H6 Between LuxR-transcriptional
regulator and a hypothetical protein
KpST66_1827 and KpST66_1828 Between KPN_00784 and KPN_00785 Y/Y
P048H7 Between putative glutathione S-transferase
and D-alanyl-D-alanine carboxypeptidase;
penicillin-binding protein
KpST66_1922 and KpST66_1923 Between KPN_00870 and KPN_00871 Y/Y
P043E6 Between deoR and deoC KpST66_2811 and KpST66_2812 Between KPN_01701 and KPN_01702 Y/Y
P038G8 Between aspartate-semialdehyde
dehydrogenase and a putative transcriptional
regulator
KpST66_2862 and KpST66_2863 Between KPN_01773 and KPN_01774 Y/Y
P019E6 Between putative transposase IS4
and a putative ARAC-type regulatory protein
KpST66_2869 and KpST66_2870 Between KPN_01779 and KPN_01780 Y/Y
P037E9 Between putative FAD/FMN-containing
dehydrogenases and a hypothetical protein
KpST66_3144 and KpST66_3145 Between KPN_02042 and KPN_02043 Y/Y
P022H9 Between putative enzyme and
hypothetical protein
KpST66_3460 and KpST66_3461 Between KPN_02355 and KPN_02356 Y/Y
P025H3 Between putative transcriptional regulator and
putative arylsulfatase regulator
KpST66_4042 Between KPN_02830 and KPN_02831 Y/Y
P050B12 Between iap and cysH KpST66_0997 and KpST66_0998 Between KPN_03116 and KPN_03117 Y/Y
P005D9 Between uppP and folB KpST66_0645 and KpST66_0646 Between KPN_03461 and KPN_03462 Y/Y
P015G5 Between two hypothetical proteins KpST66_0630 and KpST66_0631 Between KPN_03477 and KPN_03478 Y/Y
P006F8 Between yhdP and rng KpST66_0465 and KpST66_0466 Between KPN_03654 and KPN_03655 Y/Y
P028H3 Between ibpA and yidQ KpST66_0014 and KpST66_0015 Between KPN_04091 and KPN_04092 Y/Y
P041H3 Between rimI and ygjF KpST66_5016 and KpST66_5017 Between KPN_04415 and KPN_04416 Y/Y
P024D12 Between yhaM and psiE KpST66_5012 and KpST66_5013 Between KPN_04419 and KPN_04420 Y/Y
P051G11 Between phnA and proP KpST66_4928 and KpST66_4929 Between KPN_04502 and KPN_04503 Y/Y
P014F6 Between YgfA and traM pKpST66–1_0029 and pKpST66–1_0030 Between KPN_pKPN3p06000 and
KPN_pKPN3p06001
Y/Y
P014E6 Between hypothetical protein and iutA pKpST66–2_0063 and pKpST66–2_0064 Between LV106-LV107 Y/Y
a Growth in M9 agar plates was supplemented with either glucose or citrate as the carbon source. N, no growth; Y, growth.
b Present only in the Kp52145 genome.
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FIGURE 3. Indirect role ofK. pneumoniae enterobactin in attenuation ofNF-Bactivation.A, growth of Kp52145 (black symbols) and enterobactinmutant
(52entF::tn5,white symbols) in LB supplement with 2-2-dipyridyl (DIP). B, SEAP levels released by A549-SEAP A2 cells left untreated (control (CON)) or infected
with different Klebsiella strains. Scale bars representmean	 S.E. (n
 3).C, immunoblot analysis of IB and tubulin levels in A549 cells left uninfected (control)
or infectedwith Kp52145 or enterobactinmutant (52entF::tn5) for 3 h. Data are representative of three independent experiments.D, analysis of the expression
of iutA, psn, ybtA, and entC by Kp52145 carrying the transcriptional fusions iutA::gfp, psn::gfp, ybtA:;gfp, and entC::gfp. Bacteria were grown in LB (white bars),
RPMI 1640 (graybars), or LB supplementwith2-2-dipyridyl (DIP,blackbars). Data arepresentedasmean	S.D. (n
3). E, adhesion (left bars) and internalization
(right bars) of Klebsiella strains to A549 cells (n
 3). F, SEAP levels released by A549-SEAP A2 cells left untreated (control,white bar) or infected with Kp52145,
capsule mutant (52145-wzaK2), enterobactin mutant (52entF::tn5), or capsule and enterobactin double mutant (52145-wzaK2entF). Scale bars represent
mean	 S.E. (n
 3). ns (not significant), p 0.05; *, p 0.05; **, p 0.01 (one-tailed t test).
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wild-type strain (Fig. 4C). Many cellular stimuli also activate
MAPK pathways. The activation of the three MAPKs (p38,
JNK, and p44/42) occurred through phosphorylation of serine
and threonine residues. All strains induced the phosphoryla-
tion of the three MAPKs; however the phosphorylation of p38
and p44/42 was more apparent in cells infected with the ligase
andOPSmutants than in those infected with the wild type (Fig.
4D). No differences were observed between both mutants (Fig.
4, C and D). Altogether, these results support the view that
Kp52145 OPS is required to attenuate inflammation.
waaL mutants express similar levels of CPS as the wild type
(Ref. 50 anddata not shown). To assess the relative contribution
of CPS andOPS to attenuate NF-B activation, we investigated
whether the absence of OPS increases SEAP levels induced by
the cpsmutant. Results shown in Fig. 4E confirmed that thiswas
the case.
To further analyze the contribution of the LPS polysaccha-
ride section to the attenuation of NF-B activation, we sought
to determine whether the LPS core section plays any role in
Klebsiella attenuation of NF-B activation. wabM, wabK, and
wabH mutants lack, in addition to the OPS, the first, second,
and third sugars of the LPS core, respectively (50), but they
express similar levels of CPS as the wild type (50). The three
mutants triggered the secretion of SEAP by infected cells (Fig.
4E). SEAP levels were higher than those induced by the wild
type; the levels induced by the wabM and wabK mutants were
also significantly higher than those induced by the waaL
mutant (Fig. 4E). No significant differences were found
between the wabM and wabKmutants (Fig. 4E). In the genetic
background of the cps mutant, the wabM and wabK mutants
induced similar levels of SEAP, which were higher than those
triggered by thewaaLmutant (Fig. 4E). SEAP levels induced by
the wabH mutant were not significantly different than those
induced by the waaL mutant (Fig. 4E). Comparatively similar
results were found when the secretion of IL-8 was evaluated
(Fig. 4F). Collectively, these data show that the CPS, the OPS,
and the first glucose of the core are bacterial factors required to
attenuate the activation of NF-B by epithelial cells upon
K. pneumoniae infection.
Recently, we have shown that Kp52145 attenuates proin-
flammatorymediator-inducedNF-B activation (22). This pro-
cess requires bacteria-cell contact, and removal of bacteria by
washing followed by a 1-h gentamicin treatment renders the
cells responsive to agonist-induced IL-8 secretion (22). To exert
this anti-inflammatory effect, Kp52145 engages NOD1 and
EGFR receptors (22, 24). To explore whether the OPS could
account for the Kp52145 anti-inflammatory effect, we deter-
mined the effect of the waaL mutant on IL-1-induced IB
degradation using the assay that we described previously (22,
24). Similar to Kp52145, waaL attenuated IL-1-induced IB
degradation (Fig. 4G). As with the wild type, this effect was
abrogated in cells in which NOD1 and EGFR were knocked
down using siRNA (Fig. 4H).
Control experiments revealed that the ligase and core
mutants adhered to A549 cells in higher numbers than the wild
type (for each comparison between Kp52145 and the mutants,
p  0.05 (one-tailed Student’s t test)) (Fig. 4I). The adhesion
levels of the wabM and wabKmutants were higher than that of
the waaL mutant (Fig. 4I). As reported previously (49), strains
lacking CPS adhered in higher numbers than CPS-expressing
strains (for each comparison between CPS-expressing and
CPS-negative strains, p 0.01 (one-tailed Student’s t test)) (Fig.
4I). In the cpsmutant background, no significant differences in
adhesion between strains were found (Fig. 4I). waaL and core
mutantswere internalized in higher numbers than thewild type
(for each comparison between Kp52145 and the LPS mutants,
p 0.01 (one-tailed Student’s t test)) (Fig. 4I). In the cpsmutant
background, however, waaL, wabM, and wabK mutants were
internalized in lower numbers than the cpsmutant (Fig. 4I), and
the levels were not significantly different than those of the wild
type (for each comparison between Kp52145 and the LPS
mutants, p  0.05 (one-tailed Student’s t test)). Interestingly,
wabH mutant displayed internalization levels similar to those
of the cpsmutant (Fig. 4I).
Finally, we sought to determine the innate receptor(s)
involved in the recognition of the OPS mutant by using as cel-
lular readouts of the NF-B-dependent secretion of SEAP and
the secretion of IL-8. Almost all TLRs activate cellular signaling
pathways through TIR domain-mediated interactions with the
adaptor molecule MyD88 (52). To explore the involvement of
TLRs in waaL mutant-induced cell activation, the function of
the MyD88 adaptor molecule was interrupted by siRNA. In
MyD88 knocked-down cells,waaLmutant induced neither the
activation of the NF-B reported construct nor the secretion of
IL-8 (Fig. 5, A and B, respectively). To further dissect the con-
tribution of TLR-dependent signaling towaaLmutant-induced
cell activation, TLR2 and TLR4 were knocked down by siRNA.
The results shown in Fig. 5 indicate that both receptors contrib-
uted to waaL-induced cell activation. On the whole, these data
suggest that waaL mutant induced NF-B activation and IL-8
secretion is mediated by TLR4-TLR2-MyD88 pathway.
Analysis of the PullulanaseMutants—Two transposon inser-
tions were found in the pulC and loci. pulC is the first locus of
the Klebsiella T2SS that secrets the enzyme pullulanase
encoded by pulA (53). yacC encodes for a lipoprotein contain-
ing a domain related to the pulS/outS family but for which the
FIGURE 4. K. pneumoniae LPSO-polysaccharide is implicated in attenuation of NF-B activation. A, LPS analysis by SDS-PAGE. Data are representative of
three independent experiments. B, SEAP levels released by A549 cells left untreated (control (CON), white bar) or infected with Kp52145 or waaL mutants
(52waaL::tn5 and 52waaL). Scale bars represent mean	 S.E. (n
 3). C, immunoblot analysis of IB and tubulin levels in A549 cells left uninfected (control)
or infectedwith the indicated strains for 3 h. Data are representative of three independent experiments.D, immunoblots showing phosphorylatedMAPKs and
tubulin levels in cell extracts of A549 cells left uninfected (control, time 0) or infected with K. pneumoniae strains for different times. The results are represen-
tative of three independent experiments. E, SEAP levels released by A549 cells left untreated (control,white bar) or infected with the indicated strains (n
 3).
F, ELISA of IL-8 released by A549 cells left untreated (control,white bar) or infected for 12 h with the indicated strains (n
 3). G and H, immunoblot analysis of
IB and tubulin levels in lysates of A549 cells infectedwith the indicated strains. The cellswere left untreated, stimulatedwith IL-1 (1 ng/ml, 10min), infected
for 3 h, or infected for 3 h and then stimulated with IL-1. In H, the siRNA targets are indicated in the top row of each panel. (AS, AllStars control siRNA). Data
are representative of three independent experiments. I, adhesion (left panel) and internalization (right panel) ofKlebsiella strains toA549 cells (n
 3). *,p 0.05
(one-tailed t test); ns (not significant), p 0.05 (one-tailed t test). In E and F, CPS-expressing strains, gray bars; CPS negative strains, black bars.
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exact function has not yet been described. To help understand
the contribution of Klebsiella T2SS to NF-B attenuation, we
constructed a pulA mutant, because PulA is the only known
protein secreted by K. pneumoniae T2SS (54). Immunoblot
analysis confirmed the absence of the enzyme pullulanse in the
outer membranes of the pulC and yacC mutants and, as
expected, also in the outer membrane of the pulAmutant (Fig.
6A). The amount of cell-bound CPS expressed by the mutants
was quantified, and no differences were found between the CPS
expressed by the wild type (11.49	 1.91 mg/107 cells) and the
CPS expressed by any of the mutants (52pulA, 15.21 	 3.65
mg/107 cells; 52pulC::tn5, 9.44 	 2.91 mg/107 cells; and
52yacC::tn5, 13.26 	 4.97 mg/107 cells; for each comparison
between wild-type CPS levels and mutant levels, p 0.05, one-
tailed Student’s t test). Control experiments revealed that the
adhesion levels of the pulC and yacCmutants were higher than
those of the pulA and Kp52145 strains, which in turn, were not
significantly different (Fig. 6B). In contrast, no significant dif-
ferences were found in the internalization to cells between any
of the strains (Fig. 6B).
SEAP levels induced by the T2SS mutants were higher than
those induced by the wild type (Fig. 6C), and IB levels were
lower in those cells infected with the T2SS mutants (Fig. 6D).
Complementation of the pulAmutant restored the SEAP levels
to those triggered by the wild type, and we found an increase in
the levels of IB in the lysates of infected cells (Fig. 6,C andD).
Cells infected with the pulAmutants also secreted higher levels
of IL-8 than cells infected with the wild type (Fig. 6E). Comple-
mentation of the mutant restored IL-8 secretion to wild-type
levels. We also evaluated the activation of MAPKs in pulA
mutant-infected cells. Western blot analysis shown in Fig. 6E
revealed that infectionwith thepulAmutant triggered thephos-
phorylation of the threeMAPKs. Phosphorylation levels of p38
and p44/42 were higher at 60 and 90min post-infection in cells
infected with the pulA mutant than in those infected with
Kp52145 (Fig. 6E). Kp52145 and pulAmutant triggered similar
levels of phosphorylated JNK (Fig. 6E). In aggregate, these find-
ings indicate that K. pneumoniae that PulA contributes to lim-
iting the activation of the NF-B canonical pathway and
MAPKs p38 and p44/42.
We next sought to clarify whether T2SS-secreted PulA is
required for K. pneumoniae anti-inflammatory phenotype (22,
24). Similar to Kp52145, pulA mutant attenuated IL-1-in-
duced IB degradation (Fig. 6G). Furthermore, this effect was
dependent on NOD1 and EGFR, because the pulAmutant did
not block cytokine-triggered IBdegradation inNOD1-EGFR
knockdown cells (Fig. 6H).
siRNA-based experiments were carried out to investigate
whether aTLR-MyD88-dependent pathway is implicated in the
recognition of the pulA mutant. SEAP levels induced by the
pulAmutant were reduced to those induced by the wild type only
inMyD88knocked-downcells and inTLR2-TLR4knocked-down
cells (Fig. 7A). Likewise, pulA mutant-triggered IL-8 secretion
was also dependent on TLR4-TLR2-MyD88 (Fig. 7B). Alto-
gether, our results demonstrated that K. pneumoniae PulA is
required to attenuate the activation of NF-B by limiting the
activation of a TLR4-TLR2-MyD88 pathway.
Relative Contribution of CPS, O-polysaccharide, and pulA to
K. pneumoniae Attenuation of Inflammation—The fact that
CPS, LPS OPS, and PulA are all involved in attenuating inflam-
matory responses led us to study the relative contribution of
each of these factors. Therefore, we asked whether the absence
of PulA further increases the SEAP levels and the secretion of
IL-8 induced by the cps and waaL mutants. Data displayed in
Fig. 7A show that SEAP levels induced by the double mutant
waaL-pulA were higher than those induced by either the waaL
or pulA single mutant. In turn, waaL-infected cells secreted
higher SEAP levels than cells infected with the pulA mutant
(Fig. 8A). In the cpsmutant background, the strain inducing the
highest SEAP levels was the double mutant waaL-pulA. No
significant differences were observed between the waaL and
pulA mutants. Similar picture was obtained when the IL-8
secretion was used as read out for cellular activation (Fig. 8B).
Collectively, these data show that the CPS, the LPS OPS and
FIGURE5.RoleofMyD88, TLR2, andTLR4 inK. pneumoniaewaaLmutant-
induced cell activation. A, SEAP levels released by A549 cells transfected
with the indicated siRNAs for different pattern recognition receptors, which
were left untreated (control (CON), white bars) or infected with Kp52145 or
waaL mutant (n
 3). B, ELISA of IL-8 released by A549 cells transfected with
either control or the indicated siRNA for different pattern recognition recep-
tors, which were left untreated (control, white bars) or infected (n
 3). Scale
bars represent mean	 S.E. **, p  0.01; *, p  0.05 (results are significantly
different from the results obtained by infecting control siRNA-transfected
cells withwaaLmutant; one-way ANOVA).
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PulA are Klebsiella factors require to limit NF-B activation
and the secretion of IL-8 by infected epithelial cells.
Virulence of K. pneumoniae Mutants—To determine the
ability of pulA and waaL mutants to cause pneumonia, CD-1
mice were infected intranasally, and 24 h post-infection the
bacterial loads in trachea, lung, spleen, and liver homogenates
were determined. No differences were found in the bacterial
loads in the trachea (Fig. 9A). In contrast, the bacterial loads of
the pulA and waaL mutants were significantly lower in lung,
spleen, and liver than those of the wild type (Fig. 9A).
We also assessed by RT-qPCR the expression levels of kc and
tnf cytokines in the lungs of infected mice. The levels of kcwere
higher in lungs of infectedmice than in lungs of non-infected ani-
mals (p 0.05 for all comparisons versus non-infectedmice; one-
FIGURE 6. K. pneumoniae PulA T2SS is required for attenuation of NF-B activation. A, immunoblot analysis of PulA levels in the outer membranes of
Klebsiella strains. An asterisk marks a protein also recognized by the anti-PulA antibody, which served as a loading control. Data are representative of three
independent experiments. B, adhesion (left panel) and internalization (right panel) of Klebsiella strains to A549 cells (n
 3).C, SEAP levels released byA549 cells
left untreated (control (CON), white bar) or infected with the indicated strains. Scale bars represent mean	 S.E. (n
 3). D, immunoblot analysis of IB and
tubulin levels in A549 cells left uninfected (control) or infected for 3 h. Data are representative of three independent experiments. E, ELISA of IL-8 released by
A549 cells left untreated (control,white bar) or infected for 12 hwith the indicated strains (n
 3). F, immunoblots showingphosphorylatedMAPKs and tubulin
levels in cell extracts of A549 cells left uninfected (control, time 0) or infected with K. pneumoniae strains for different times. The results are representative of
three independent experiments. G and H, immunoblot analysis of IB and tubulin levels in lysates of A549 cells infected with the indicated strains. The cells
were left untreated, stimulatedwith IL-1 (1 ng/ml, 10min), infected for 3 h, or infected for 3 h and then stimulatedwith IL-1. InH, siRNA targets are indicated
in the top row of each panel (AS, AllStars control siRNA). Data are representative of three independent experiments. *, p  0.05 (results are significantly
different from the results for Kp52145; one-tailed t test). ns (not significant), p 0.05 (for the indicated comparisons; one-tailed t test).
FIGURE 7. Role ofMyD88, TLR2, and TLR4 in K. pneumoniae pulAmutant-
induced cell activation. A, SEAP levels released by A549 cells transfected
with the indicated siRNAs for different pattern recognition receptors, which
were left untreated (control (CON), white bars) or infected with Kp52145 or
pulA mutant (n
 3). B, ELISA of IL-8 released by A549 cells transfected with
either control or the indicated siRNA for different pattern recognition recep-
tors, which were left untreated (control, white bars) or infected (n
 3). Scale
bars represent mean	 S.E. **, p  0.01; *, p  0.05 (results are significantly
different from the results by obtained infecting control siRNA-transfected
cells with pulAmutant; one-way ANOVA).
FIGURE 8. Relative contribution of CPS, LPS O-polysaccharide, and PulA
T2SS to K. pneumoniae-triggered attenuation of NF-B activation. A,
SEAP levels released by A549 cells left untreated (control (CON),white bar) or
infected with the indicated strains (n
 3). B, ELISA of IL-8 released by A549
cells left untreated (control,white bar) or infected for 12 h with the indicated
strains (n
 3). Scale bars represent mean	 S.E. CPS-expressing strains, gray
bars; CPS negative strains, black bars. *, p 0.05 (for the indicated compari-
sons, one-tailed t test).
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tailed t test) (Fig. 9B). However, kc levels were significantly higher
in the lungs ofmice infectedwith pulA andwaaLmutants than in
those infected with the wild type (Fig. 9B). tnf levels were higher
in the lungs of mice infected with pulA mutant than in those
infected with the wild type or thewaaLmutant.
Discussion
We recently showed that K. pneumoniae dampens the acti-
vation of inflammatory responses in host cells by targeting the
activation of the NF-B canonical pathway (22, 24). Our results
revealed thatK. pneumoniaeCPS is necessary but not sufficient
to attenuate inflammation (22, 24). To identify additionalKleb-
siella factors required to dampen inflammation, we stan-
dardized and applied a high-throughput gain-of-function
screen, mining a Klebsiella transposon mutant library. Using
this approach,we identified 114mutants that triggered the acti-
vation of NF-B. Follow-up validation uncovered that, in addi-
tion to the CPS, K. pneumoniae LPS OPS and the pullulanase
T2SS are required for evasion of innate immune responses.
Table 3 summarizes the findings obtained in this study. This
study represents the first functional genomics-driven identifi-
cation of previously unknown bacterial factors required to
down-regulate the NF-B signaling pathway.
The high number of Klebsiella loci involved in the attenua-
tion of NF-B activation was somewhat unanticipated. To the
best of our knowledge the majority of the loci identified in our
screening have never been implicated in NF-B control, and
even the function of most of them is largely speculative, as it is
based on in silico predictions. Nevertheless, it should be noted
that the transposon mutant library examined is not saturated,
hencemaking it possible that additional loci are needed for fully
effective immune evasion. For example, in our screeningwe did
not retrieve any cps mutant, despite the fact that CPS plays a
crucial role in Klebsiella anti-immune strategies (8, 20, 24).
However, this is not unprecedented in this type of studies; for
example, cps mutants were not isolated in other Klebsiella
screenings searching for virulence factors (4, 55, 56).
The two gene ontology categories including half of the loci
identified in the screening are: metabolism and transport, 32%
FIGURE 9. Virulence of K. pneumoniae waaL and pulAmutants. A, bacterial counts in mouse organs at 24 h post-infection. Mice were infected intranasally
with the indicated strains (Kp52145,f),pulAmutant (52pulA,E) orwaaLmutant (52waaL,). Resultswere reported as log cfu/g of tissue. **,p 0.01; *,p
0.05 (results are significantly different from the results obtained infecting with Kp52145; one-way ANOVA). B, kc and tnfmRNA expressions in whole lungs
wereassessedbyRT-qPCR.Micewerenon-infected (control (CON),whitebars,n
5)or infectedwithKp52145 (blackbars,n
5)orwaaLandpulAmutants (gray
bars;n
 5 for eachmutant). Scale bars representmean	 S.E. *, p 0.05 (results are significantly different from the results obtainedby infectingwith Kp52145;
one-way ANOVA).
Klebsiella pneumoniae Anti-inflammation
JULY 3, 2015•VOLUME 290•NUMBER 27 JOURNAL OF BIOLOGICAL CHEMISTRY 16693
 at Instituto de Investigaciones Biom
edicas on June 19, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
of themutants, and envelope-related genes, 17%of themutants.
None of the metabolic and transport mutants displayed any
growth defects under the screening conditions or in LB, hence
making it unlikely that any gross growth defect underlies the
activation of NF-B in infected cells. As this will be the subject
of future studies, at present we speculated that their contribu-
tion to Klebsiella immune evasion is indirect and related to
their impact on other Klebsiella factors. Supporting this
hypothesis, the follow-up analysis of the enterobactin mutant
revealed that the lack of the siderophore is linked to a reduced
CPS expression, which in turn explains the NF-B activation
induced by the mutant. The regulatory connection between
iron levels and CPS expression has been already established
(48). Because our wild-type strain encodes for two additional
iron-scavenging systems, yersiniabactin and aerobactin, we
sought to determine whether any Klebsiella siderophore
mutant would induce NF-B activation. However, and in good
agreement with Lawlor et al. (9), enterobactin was the only
siderophore expressed under our infection conditions. There-
fore, it was not unexpected to find that themutants in the other
two scavenging systems did not activate NF-B. Nonetheless,
the evidence indicates that yersiniabactin is the Klebsiella sid-
erophore that plays a dominant role in vivo (9), hence making
possible that yersiniabactin would be the siderophore impli-
cated in Klebsiella immune evasion during pneumonia.
The other major set of mutants were related to envelope
structures, thereby adding further evidence to the critical role
played by bacterial surface structures on host-pathogen inter-
actions. Although in this work we have characterized only the
role of the OPS and T2SS systems, it is worth discussing the
possible contribution of the peptidoglycan and adhesion
mutants toKlebsiella immune evasion. The seminal discoveries
showing that NOD receptors recognize peptidoglycan motifs
from Gram-negative bacteria provide a mechanistic explana-
tion for the observation that peptidoglycan mutants induce
NF-B activation (57, 58). This is because thesemutants secrete
peptidoglycan fragments into the medium, which then activate
NOD1 (59). Future efforts in our laboratory will confirm
whether this is the case with our set of mutants. In addition, we
will be eager to explore whether K. pneumoniae remodels its
peptidoglycan to attenuate detection by NOD receptors.
In our previous studies we did demonstrate that Klebsiella-
cell contact is essential to attenuate NF-B activation (22). In
this scenario, it can be predicted that any mutant deficient in
adhesion will be affected on its ability to block NF-B activa-
tion. Of note, in our recent siRNA-based screening we uncov-
ered the fact that Klebsiella may manipulate the 1-integrin-
ILK signaling cascade to dampen inflammatory responses (24).
1-integrins are used by many pathogens as cellular receptors
for attachment (60). It is then tempting to speculate that the
adhesion-relatedmutants found in the present studymight not
be able to target the 1-integrin-ILK signaling cascade.
The LPS OPS is perhaps the most widely found factor in any
screen designed to identify virulence factors of Gram-negative
bacteria. However, to the best of our knowledge, ours is the first
screening to demonstrate its involvement in attenuatingNF-B
activation. The fact that the double mutant lacking CPS and
OPS induced higher responses than each of the single mutants
indicates that theKlebsiella polysaccharides do not play redun-
dant roles in host-Klebsiella interactions. Having established the
role of the OPS, we next investigated whether LPS core res-
idues may also participate in immune evasion. To investigate
the contribution of core residues in an OPS-bearing strain, we
used defined mutants that lack the OPS in addition to core
residues, which in turnmight suggest that the core residueswill
never be exposed in a wild-type strain. However, it should be
noted that epidemiological data indicate that nearly 10% of
Klebsiella clinical isolates do not express the LPS OPS (61),
and therefore, core residues will not be masked by the OPS.
Our results revealed that the first glucose residue of the LPS
core is necessary to attenuate NF-B activation, because the
SEAP levels induced by the wabMmutant, lacking also OPS,
were higher than those triggered by the OPS mutant. Elimi-
TABLE 3
Summary of the phenotypes displayed by the K. pneumoniaemutants characterized in this study
NT, not tested; —, no capsule;, similar to the wild-type strain;1, higher/stronger than the wild type, where the number of arrows gives an indication of relative levels
compared with the wild type;2, less than the wild type.
Klebsiella factor
Phenotype of the mutants
Adhesion/internalization CPS levels NF-B activationa
MAPK activationb
TLR signalingcp38 p44/42 JNK
Siderophores
entF 1 2 11 NT NT
cps-entF NT — 11 NT NT
iutA NT NT  NT NT
Irp1 NT NT  NT NT
LPS
waaL   1 1 1  Yes
glf   1 1 1  NT
wabM   11 NT NT
cps-waaL  — 11 NT NT
cps-wabM 1 — 1111 NT NT
T2SS
pulA   1 1 1  Yes
cps-pulA NT — 11 NT NT
cps-waaL-pulA NT — 1111 NT NT
a SEAP levels as read-out.
b Phosphorylation of the MAPKs as read-out.
c IL-8 secretion and SEAP levels are dependent on the TLR4-TLR2-MyD88 signaling pathway.
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nation of additional core residues did not further increase
the SEAP levels.
The invasion experiments revealed unexpected features of
the contribution of CPS and LPS to Klebsiella interaction with
epithelial cells. Available evidence supports the notion that
Klebsiella CPS is the critical factor preventing Klebsiella inter-
nalization by epithelial cells (49).Our data further corroborated
this notion but also highlighted the contribution of OPS and
core residues. However, in the absence of CPS, the D-galactan
OPS mediates Klebsiella internalization by epithelial cells
because the internalization of those mutants lacking the OPS,
mutants waaL, wabM, and wabK, was reduced to the levels of
the wild-type strain. Surprisingly, the internalization levels of
the wabH mutant were similar to those of the CPS mutant.
Structural studies showed that a core galactose residue gets
exposed in thismutant (50), which in turn could account for the
mutant internalization.
The contribution of the LPS core to virulence is poorly char-
acterized in most Gram-negative pathogens, and it has been
rigorously established only for Yersinia enterocolitica and
Kp52145 (50, 62). In a previous study we uncovered the contri-
bution of the Klebsiella core in preventing macrophage phago-
cytosis (6), which, together with the evidence presented in this
work, led us to put forward the notion that core residues are
important for Klebsiella immune evasion. Interestingly, this
might be a general feature of LPS core sections, as it has been
reported recently that Brucella abortus core acts as a shield
against immune recognition (63). Future studies testing addi-
tional pathogens should help to further validate this hypothesis.
In this work, we discovered that Klebsiella pullulanase T2SS
is important for immune evasion in vitro and in vivo. The Kleb-
siellapullulanase secretion system is the archetype ofT2SS, and
most of the previous research efforts have beendevoted to char-
acterizing themolecular structure and function of the secretion
system (54). However, its contribution toKlebsiella virulence, if
any, was unknown. Perusal of the literature indicates that PulA
is the only protein secreted by K. pneumoniae T2SS, although
presently we cannot rigorously rule out that other proteins yet
to be found are also secreted by the system. Nonetheless, the
fact that SEAP levels induced by the pulA, pulC, and yacC
mutants were not significantly different may support the idea
that indeed the only protein secreted by the T2SS is PulA. Tak-
ing into account the evidence available for similar enzymes
from other pathogens (64, 65), we speculate that PulA interacts
with glycan(s) located in the epithelial surface, hence leading to
limited activation of the TLR4-TLR2-MyD88 pathway upon
Klebsiella infection. Future efforts of the laboratory will be
devoted to identify these host glycan(s).
In this work, we have demonstrated for the first time, using a
pneumonia mouse model, that PulA is important for bacterial
survival in the lung. Research over the last 20 years has demon-
strated a correlation between the activation of inflammatory
responses and Klebsiella clearance from the airways (11–14).
Hence the higher inflammatory response induced by the pulA
mutant may contribute tomutant clearance. It should be noted
that cytokines and chemokines released by epithelial cells do
increase the bactericidal activity of professional phagocytes.
Studies are ongoing to determine whether PulA plays any role
in the interaction of K. pneumoniaewith alveolar macrophages
and neutrophils.
Recently, we demonstrated that K. pneumoniae exerts an
anti-inflammatory effect by engagingNOD1andEGF receptors
(22, 24). Bacterial removal by gentamicin treatment renders
cells again responsive to pro-inflammatory mediators (22).
Considering that CPS is necessary but not sufficient to attenu-
ate inflammation (22, 24), in this work we asked whether OPS
and PulA could mediate this anti-inflammatory effect. How-
ever, our findings shown in Figs. 4 and 6 do not support this.
These results do not contradict the other findings reported in
this work showing that OPS and T2SSmutants activate inflam-
matory responses. It should be noted that in most of the exper-
iments in this study gentamicin was used to remove bacteria
after a 2-h infection; for example, IL-8 in the supernatants was
measured at 12 h post-infection. In turn, the fact thatwaaL and
pulA mutant-induced responses were dependent on TLR2-
TLR4-MyD88 activation suggests that OPS and PulA perturb
TLR-dependent recognition of K. pneumoniae. These results
further corroborate in vitro and in vivo data showing that TLR2
and TLR4 play a dominant role in detecting K. pneumoniae
infections (20, 66, 67).
On the whole, the evidence is consistent with the notion that
an essential aspect of K. pneumoniae infection biology is to
thwart the TLR-dependent activation of host defense responses.
Our studies have revealed the concerted action of CPS, OmpA,
LPS polysaccharide, and T2SS to prevent TLR-dependent
responses (this work and others (8, 20, 21)). Further highlight-
ing the importance of immune evasion for Klebsiella virulence,
all of these mutants are attenuated in the pneumonia model
(this work and others (3, 8)). Therefore, we put forward the
notion that a new therapeutic approach to the treatment of
Klebsiella infections will be to prevent this virulence strategy,
either by using molecules directed to block some of these fac-
tors or by increasing TLR-governed defense responses. Sup-
porting the feasibility of the latter approach, the administration
of the TLR ligand CpG augments anti-Klebsiella immunity in
pneumonia (17).
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